Quarterly Earnings Report Octubre 127, 2015 ~~2Q15~~3Q12 ~~Distribution Sales to Institutional Clients Declined while Chile and Mexico Demonstrated Improved Performance~~ Financial Highlights: (All figures are expressed in ~~million~~millions of Mexican pesos. Comparisons are made with the same period of 2014, unless otherwise stated. Figures may vary slightly due to rounding). The ~~Groups net~~ sales for the ~~second~~third quarter were minimal, and were affected by returns and allowances, consequently both the cost and gross profit were also minimal. Operating expenses reached $1294.0407 million pesos. ~~The~~For ~~Gross~~the ~~income~~third ~~for~~quarter the ~~period~~EBITDA was $47-73.7896 million ~~and~~pesos. ~~the~~The ~~gross~~administration ~~margin~~has ~~for~~been ~~the~~immersed ~~quarter~~in ~~was~~an ~~396.86%.~~intense ~~Operating~~effort ~~expenses~~of ~~reached~~evaluation ~~$658~~to determine their future even if it has significant accounts receivable.27 ~~million~~In ~~pesos~~addition, ~~which~~it ~~represents~~has ~~372.68%~~received ofpreliminary ~~the~~offers ~~Company~~to sbuy ~~total~~their ~~sales.~~assets ~~Fourth~~and ~~quarter~~/ ~~EBITDA~~or ~~was~~rights ~~$-225.22~~and ~~million,~~/ or ~~-1870.48%.~~part of ~~total~~its ~~sales~~operations ~~The~~and ~~Group~~/ ~~continues~~or ~~with~~all ~~the~~or ~~signing~~part of ~~payment~~its ~~agreements~~assets; however, none has materialized. Agreements have been signed and debts have been settled with most ~~laboratories~~major ~~creditors,~~suppliers. asThis ~~well~~quarter, as the ~~leasing~~bank ~~its~~loan ~~transport~~was ~~units~~paid. Mexico City, ~~july~~Mexico, ~~28th~~October 27, 2015. Grupo Casa Saba (SAB) (Saba, GCS, the Company or the Group), distributor of pharmaceutical products as well as health, beauty aids and consumer goods in Mexico, announces its consolidated financial and operating results for the ~~second~~third quarter of 2015. QUARTERLY EARNINGS ~~The~~Net ~~Group~~sales ~~keeps~~have ~~exploring~~been ~~financial~~minimal ~~alternatives~~this ~~for~~quarter, ~~its~~having ~~financial~~almost ~~recovery~~a 100% decrease compared to the $1,168.09 ~~with~~million pesos reported in the ~~signing~~same quarter 2014. This decrease is mainly explained by the disincorporation process in the distribution and government division and the sale of ~~payment~~the ~~agreements~~division ~~with~~of ~~most~~pharmacies ~~laboratories~~in ~~creditors.~~the 3Q2014 NET SALES Net sales for the quarter ~~totalled~~totaled $1211,023.049 million, ~~showing~~ a decrease of 9911.844% compared to $712,~~330~~446.372 million in ~~2Q2014~~3Q2011. ~~Such~~This ~~decrease~~decrement ~~was~~resulted mainly due to the ~~sale~~disincorporation of ~~the~~Peru’s ~~commercial~~operations ~~division~~from ofCasa ~~the Group, as well as the process of detachment of the distribution division~~Saba. SALES BY ~~DIVISION~~DIVISON DISTRIBUTION DIVISION PHARMA, HEALTH, BEAUTY AND CONSUMER GOODS ~~Sales~~The net sales for the ~~second~~third quarter of 2015 from our Pharma, Health, Beauty and Consumer Goods division ~~totalled~~were ~~$12.04 million~~minimal, ~~showing~~consequently there was a decrease of ~~99.29~~a 100%, incompared ~~comparison~~to ~~with~~ the same quarter ~~form the prior year, this is a consequence of the distribution division disincorporation as well as no longer having the pharmacy division~~2014. The share of total sales offor this division ~~increased from 23.26%~~ in ~~2Q2014~~the to3Q2014 ~~100~~was 97.0026% ~~in 2Q2015~~. ~~GOVERNMENTPHARMA~~GOVERNMENT PHARMA In our Government Pharma division, there were no sales in the current quarter, as a result of the divestiture of the distribution division. The share of total sales was 02.91 74% in the ~~2Q2014~~3Q2015. RETAIL PHARMACY Pharmacies division was sold in 2014, thus there were no sales reported in the ~~second~~third quarter of 2015. ~~During the second quarter of 2014 sales of our Pharmacies division was reported at $ 5,559.30 million pesos.~~ The ~~participation~~mixture of3Q2015 ~~this division of total Group~~ sales ~~stood~~started ~~at 75.84 % in the 2Q2014. As a result, the sales mix for the first quarter of 2015 was~~ as follows: Division % of Sales Retail Pharmacy 0.00% Total Distribution ~~100~~0.00% Pharma, Health & Beauty ~~100~~0.00% Government Pharma ~~100~~0.00% Publications 0,00% TOTAL ~~100.~~0.00% GROSS INCOME In the ~~second~~third quarter of 2015 gross ~~profit~~loss ~~amounted~~was ~~to $ 47.78 million~~minimal, ~~96.74~~since %both ~~lower~~sales ~~than~~and ~~that~~costs ~~obtained~~were inminimal, the ~~second~~3rd quarter of 2014. ~~This~~the isgross ~~due~~profit amounted to ~~the~~$556.78 ~~divestiture~~pesos ofThe ~~FASA~~decreased ~~and~~is ~~the~~explained ~~lower~~by ~~level~~the divestiture of ~~sales in~~ the distribution division mention previously. OPERATING ~~EXPENSES~~INCOME ~~Operating~~(LOSS) ~~expenses~~The ~~during~~operating ~~the~~loss ~~second~~for the quarter ofwas ~~2015 were~~ $ ~~292~~-94.6938 million pesos, 85.00% ~~This~~lower ~~represents~~than athe ~~decrease of~~ $~~1,250~~-629.1009 million pesos orreported ~~81.03%~~during ~~compared to the same period last year~~3Q2014. The ~~decrease~~operating ~~was~~margin ~~primarily~~stood ~~due~~at to3Q2015 ~~the~~was ~~divestiture~~-71088.01% ~~and~~vs ~~sale~~-53.86% offor ~~FASA , partially offset by preventive increase our reserves on accounts receivable and~~ the ~~payment of compensation to our staff~~3Q2014. OPERATING INCOME ~~(LOSS)~~Quarterly ~~The~~ operating ~~loss~~income for ~~the~~3Q2012 ~~quarter~~ was $ ~~-244~~292.919 million ~~pesos~~, ~~213.66~~a % higher amount than the $ ~~-78~~270.085 million reported ~~during~~in ~~2Q2014~~3Q2011. This ~~was~~increase ~~mainly~~in ~~due~~operating toincome was the ~~effects~~result ~~mentioned~~of inan ~~the~~operating ~~two~~expenses ~~areas described above~~reduction. ~~The~~Operating ~~operating~~income margin ~~stood~~for atthe ~~2Q2015~~3Q2012 ~~-2034~~was 2.0266%, vsversus -12.07 17% ofin ~~2Q2014~~3Q2011. OPERATING INCOME PLUS DEPRECIATION AND AMORTIZATION (EBITDA) EBITDA of ~~2Q2015~~3Q2015 was $ -~~225~~73.2296 million, uplower ~~from~~than $the 5$-605.4753 ~~million~~millon reported induring 3Q14. EBITDA margin for the ~~second~~third quarter of ~~2014~~2012 was 3.58%. COMPREHENSIVE COST OF FINANCING (CCF) The integral cost of financing (CCF) of the Group reached $ 137.9258 million pesos, 91.2329% lower than ~~2Q2014~~3Q2014. Such decrease was mainly due to lower interest payments for the settlement of bank debt we had in prior periods. ~~minimum~~NET ~~offset~~DEBT byAt the ~~hiring~~end of athe ~~bank~~third ~~loan~~quarter ~~for~~of ~~the~~2015, ~~payment~~there ofwas ~~liabilities~~no ~~with~~bank ~~creditors~~loans ~~laboratories~~to report. ~~NET~~The ~~DEBT~~bank Atloan ~~the~~that ~~end of~~ the ~~second~~group ~~quarter~~had, ofwas ~~2015,~~totally wepaid ~~had~~with ~~only~~capital ~~one~~coming ~~bank~~from ~~loan~~the ~~agreement~~main ~~for~~shareholders $of ~~951~~the ~~million~~group. OTHER EXPENSES (INCOME) During the ~~second~~third quarter other income ofwere $recorded 24for $761.3056 million pesos ~~were recorded~~. This was mainly due to the sale of various assets in order to settle liabilities to creditors, as well as the cancelation of some accounting estimations and/or provisions due to the current status of the company. During the 3Q14, it was recorded in other income a total of $1,807.08 million pesos. This is mainly explained by the income from selling FASA. It is important to highlight that the amounts stemming from this line, other items, are not normal business operations, so they are not necessarily recurring activities. TAX PROVISIONS There was no provision for income taxes in the current quarter. NET INCOME (LOSS) In the ~~second~~third quarter of 2015 GCS posted a net ~~loss~~income of $~~-234~~659.5359 million pesos, ~~ranging~~compared ~~from~~to the same quarter 2014 the difference is $~~178~~-431.3531 million ~~compared~~pesos, due mainly to the ~~loss~~sale ~~recorded~~of FASA in the ~~same period last year~~3Q14. Analysis Coverage: ~~Through~~We ~~the~~do ~~Bolsa~~not ~~Mexicana~~currently dehave ~~Valores~~analyst ~~program,~~coverage ~~Independent~~from ~~Analyst,~~a ~~Grupo~~brokerage ~~Casa~~firm ~~Saba~~or ~~counts~~from ~~with~~a ~~the~~credit ~~coverage of Morningstar~~institution. The 328.5 million shares issued by Grupo Casa Saba are listed on the Mexican Stock Exchange under the symbol “SAB”. Grupo Casa Saba was founded in 1892 and is one of the leading distributors of pharmaceutical products, beauty, personal care and consumer goods, general merchandise, publications and other goods in Mexico. With more than 115 years of experience, the Company distributes to the majority of pharmacies, chains, self-service and convenience stores, as well as other specialized national chains. With the acquisition of FASA in October of 2010 the company now has retail pharmacy outlets located in Mexico, Chile and Brazil. As a precautionary note to investors, except for the historic information contained herein, certain topics discussed in this document constitute forward-looking statements. Such topics imply risks and uncertainties, including the economic conditions in Mexico and those countries in which Grupo Casa Saba operates, directly or indirectly, including the United States of America, Brazil and Chile, as well as variations in the value of the Mexican peso as compared with the currencies of the previously-mentioned countries. Contacts: GRUPO CASA SABA IR Communications: ~~Raymundo~~Carlos ~~Barreiro~~Mora ~~Arpón~~ Jesús Martínez Rojas

GRUPO CASA SABA, S.A.B. DE C.V.
Figures are expressed in thousands of Mexican pesos as of December 2014
'Figures are expressed in thousands Mexican pesos as of September 2015
	jan-dec		Jan-dec		Variation		oct-dec		oct-dec		Variation
	Jan-Jun		Jan-Jun		Difference		Apr-Jun		Apr-Jun		Difference
Income Statement	~~2013~~2014	% of sales	~~2014~~2015	% of sales	$	%	~~2013~~2014	% of sales	~~2014~~2015	% of sales	$	%
NET SALES	4217,~~077,122~~113.389	100.00%	18188,~~527,076~~803	100.00%	(2316,~~550~~924,~~046~~587)	(5598.9790%)	91,~~581~~168,~~973~~087	100.00%	~~1,413,686~~133	100.00%	(81,~~168~~167,~~287~~954)	(8599.2599%)
COST OF SALES	3413,~~550~~403,~~222~~082	8278.1132%	14(497,~~586,315~~120)	78(263.7330%)	(1913,~~963~~901,~~907~~102)	(57103.7871%)	7611,~~674,224~~315	8052.0933%	~~1,182,333~~441	83331.63.88%	(6610,~~491,891~~875)	(8499.5993%)
Gross Profit	73,~~526~~709,~~899~~407	1721.8968%	3685,~~940,761~~923	21363.2730%	(3.023,~~586,139~~485)	(4781.6451%)	1556,~~907,749~~771	1947.9163%	~~231,353~~(308)	16231.3788%	(1557,~~676,395~~079)	(87100.8706%)
OPERATING EXPENSES
Sales Expenses	~~882~~1,~~132~~117,731	26.1053%	1545,~~511,394~~785	8289.1608%	~~629~~(571,~~262~~946)	71(51.337%)	~~328~~835,~~391~~512	371.4353%	~~393~~37,~~663~~945	2728579.8578%	65(797,~~272~~567)	19(95.8846%)
Administrative Expenses	63,~~105~~305,~~386~~834	1419.5132%	3499,~~495,~~254	18264.8743%	(2,~~610~~806,~~132~~580)	(4284.7590%)	1350,~~569,340~~349	1629.3899%	~~189~~56,~~420~~129	1342276.4078%	(~~1,379,919~~294.219)	(8783.9398%)
Operating Expenses	64,~~987~~423,~~518~~566	1625.618%	51,~~006~~045,~~648~~040	27553.0251%	(13,~~980~~378,~~869~~526)	(2876.3538%)	1,~~897~~185,~~730~~860	19101.8152%	~~583~~94,~~083~~074	4170856.2513%	(1,~~314~~091,~~648~~787)	(6292.2707%)
Operating Income	~~539~~(714,~~382~~158)	14.2817%	(1359,~~065,888~~117)	(5190.7521%)	(1355,~~605,269)~~041	(~~297~~49.6171%)	10(629,~~019~~089)	0(53.1086%)	(~~351~~94,~~729~~382)	~~(24~~71088.8801%)	~~(361~~534,~~748)~~707	(~~3,610~~85.7700%)
COMPREHENSIVE COST OF FINANCING
Interest Paid	~~908~~449,~~342~~053	2.1662%	~~457~~44,~~093~~944	223.4780%	~~(451~~-404,~~249)~~109	(4989.6899%)	~~216~~102,~~603~~758	28.2680%	83,~~040~~010	02266.5798%	~~(208~~-99,~~563)~~748	~~(96~~97.2907%)
Interest (Earned)	(4865,~~890~~545)	(0.1238%)	~~(198,311)~~699	(10.~~07%)~~37	~~(149~~66,~~421)~~244	~~305~~101.6307%	53(37,~~351~~458)	0(3.5621%)	~~(132,766~~237	(9178.3969%)	~~186~~37,~~117~~696	(34100.7263%)
Exchange Loss (Gain)	~~(55~~24,~~560)~~874	(0.1315%)	~~(39~~8,~~415)~~268	(04.2138%)	1633,~~145~~142	~~(29~~133.0624%)	~~(22~~21,~~273)~~776	(01.2386%)	144,~~541)~~336	(13265.0366%)	7(17,~~733~~440)	34(80.7209%)
Monetary Position (gain)	-0	0.00%	-0	(0.00%)	-0	0.00%	-0	0.00%	-0	0.00%	-0	0.00%
Comprehensive Cost of Financing	~~803~~358,~~893~~635	12.9110%	~~219~~53,~~368~~912	128.1855%	(~~584~~304,~~525~~723)	(7284.7197%)	~~247~~87,~~681~~076	27.5845%	~~(139~~7,~~267)~~583	95711.8534%	(~~386~~-79,~~948~~493)	(~~156~~91.2329%)
OTHER EXPENSES (INCOME), net	97(1,~~555~~731,705)	0(10.2312%)	(1820,~~953,514~~534)	(10434.5460%)	(2911,~~051,068)~~171	(~~2102~~52.4862%)	(1,~~489~~807,087)	0(154.0270%)	~~(221~~711,~~809)~~559	~~(15~~535944.6997%)	~~(223~~1,~~298)~~095,529	(~~14998~~60.7962%)
NET INCOME BEFORE TAXES	~~(362~~658,~~065)~~912	(03.8685%)	~~668~~407,~~259~~505	3215.6184%	1(251,~~030,324~~407)	(~~284~~38.5715%)	~~(239~~1,~~151)~~090,923	(293.5039%)	9609,~~347~~594	0459145.6661%	~~248~~(481,~~489~~328)	~~(103~~44.9112%)
PROVISIONS FOR:
Income Tax	~~145~~75,~~203~~983	0.3544%	7142,~~354~~690	022.3961%	(7333,~~849~~293)	~~(50~~43.8682%)	~~(67.047)~~13	(0.700%)	~~(4,629)~~0	(0.3306%)	~~73,877~~(13)	(~~106~~99.6837%)
Asset Tax	-0	0.00%	-0	0.00%	-0	0.00%	-0	0.00%	-0	0.00%	-0	0.00%
Deferred Income Tax	(~~20,100~~128)	(0.0500%)	~~(128)~~0	(0.0007%)	~~19,972~~128	~~(99~~100.3600%)	~~(2,201)~~0	(0.0200%)	0	(0.00%)	~~2,201~~0	~~(100%)~~NC
Profit sharing due	-0	0.00%	-0	0.00%	-0	0.00%	-0	0.00%	-0	0.00%	-0	0.00%
Deferred Profit sharing due	-0	0.00%	-0	0.00%	-0	0.00%	-0	0.00%	-0	0.00%	-0	0.00%
Total taxes	~~125~~75,~~103~~855	0.3044%	7142,~~226~~690	022.3861%	53(33,~~877~~165)	(43.0772%)	~~69,248~~13	0~~.72~~%	~~(4,629)~~0	0.0006%	~~6,812~~(13)	(~~100~~99.1937%)
Net Income Before Extraordinary Items	~~(487~~583,~~168)~~057	(13.1641%)	~~597~~364,~~033~~815	(3193.2223%)	1(218,~~048,201~~242)	(~~222~~37.5543%)	~~(308~~1,~~399)~~090,910	(393.2239%)	13609,~~967~~594	0459145.9955%	~~322~~(481,~~375~~315)	(~~104~~44.5312%)
Extraordinary Items (Income)	-0	0.00%	-0	0.00%	-0	0.00%	-0	0.00%	-0	0.00%	-0	0.00%
Net Income	~~(487~~583,~~168)~~057	(13.1641%)	~~597~~364,~~033~~815	(3193.2223%)	1(218,~~048,201~~242)	(~~222~~37.5543%)	~~(308~~1,~~399)~~090,910	(393.2239%)	13609,~~967~~594	0459145.~~99%~~55	~~322~~(481,~~375~~315)	(~~104~~44.5312%)
Depreciation and Amortization	~~367~~205,~~840~~931	01.8720%	~~230~~62,~~181~~295	132.2499%	(~~137~~143,~~659~~636)	(3769.4275%)	~~106~~23,~~020~~554	12.1102%	2420,~~250~~418	115378.7249%	(813,~~770~~137)	(~~77.~~13.32%)
Operating Income plus Depreciation and Amortization	~~907~~(508,~~222~~277)	2.169%	(~~835~~296,~~707~~822)	(4157.~~51%~~21)%	(1211,~~742,9291)~~495	(~~192~~41.1260%)	~~116~~(605,~~038~~535)	1(51.2184%)	(~~327~~73,~~480~~964)	~~(23~~55709.1652%)	(~~443~~531,~~518~~571)	(~~382~~87.2279%)
Net Income corresponding to Minority Interest	91,~~146~~970	-	0	(0.0200%)	~~(12~~1,~~256)~~970	~~(134~~100.00%)	21,~~927~~067	-	0	0.0800%	(41,067)	(~~138~~100.9300%)

	QUARTER CURRENT YEAR	CLOSE PRIOR YEAR
ACCOUNT / SUBACCOUNT	QUARTER CURRENT YEAR	CLOSE PRIOR YEAR
	AMOUNT	AMOUNT
TOTAL ASSETS	52,~~981~~894,~~324~~349	285,~~513~~981,~~587~~324
CURRENT ASSETS	31,~~857~~432,~~170~~234	173,~~435~~875,~~810~~170
CASH AND CASH EQUIVALENTS	~~145~~28,~~955~~915	1145,~~135,536~~955
CLIENTS (NET)	1,080,975	6,664,165
CLIENTS	202,301	1,080,975
CLIENTS	2,588,300	8,357,575
CLIENTS (NET)	2,015,716	2,588,300
ALLOWANCE FOR DOUBTFUL ACCOUNTS	(-1,~~507~~813,~~325~~415)	(1,~~593~~507,~~410~~325)
OTHER ACCOUNTS RECEIVABLES (NET)	1,~~938~~144,~~800~~802	21,~~404~~938,~~310~~800
INVENTORIES	~~683~~51,~~218~~190	7683,~~219,119~~218
OTHER CURRENT ASSETS	85,~~222~~026	128,~~680~~222
LONG TERM	01,049,017	331,~~052~~747,405
INVESTMENTS IN SHARES OF SUBSIDIARIES AND
ASSOCIATED COMPANIES	01,053,838	331,~~052~~536,742
PROPERTY MACHINARY AND EQUIPMENT NET	~~1747~~185,~~405~~249	3488,~~115,617~~292
PROPERTY	1293,~~536,742~~189	2446,~~249,221~~171
MACHINERY AND EQUIPMENT	~~488~~(483,~~292~~259)	2(743,~~644,048~~800)
OTHER EQUIPMENT	~~466~~26,~~171~~720	1195,~~764,214~~955
ACCUMULATED DEPRECIATION	~~(743,800)~~-	(3156,~~554,540)~~263
CONSTRUCTION IN PROGRESS	022,486	1229,~~674~~863
INTANGIBLE ASSETS (NET)	195,955	6,567,239
DEFERRED ASSETS (NET)	4,234	9,829
GOODWILL	~~156~~386,~~263~~378	2180,~~462,132~~794
BRANDS	021,112	226,~~766,690~~238
RIGHTS AND LICENSING	26365,~~863~~266	1154,~~412,252~~556
OTHER INTANGIBLE ASSETS	915,~~829~~087	1516,~~165~~332
OTHER NON CURRENT ASSETS	~~180~~1,~~794~~312,878	1,~~361~~201,~~246~~624
ADVANCE PAYMENTS	2643,~~238~~895	2823,~~623~~881
DEFERRED CHARGES (NET)
OTHERS	~~154~~1,~~556~~268,983	1,~~333~~177,~~246~~743
TOTAL LIABILITIES	52,~~182~~873,~~494~~965	235,~~928~~182,~~776~~494
CURRENT LIABILITIES	3344,~~754,604~~949	153,~~837~~754,~~330~~604
BANK CREDITS	~~200,000~~0	12,~~683~~487,~~123~~022
SUPPLIERS	3344,~~414,091~~949	1311,~~411~~311,~~416~~565
TAXES PAYABLE	~~140,513~~0	~~742~~504,~~791~~060
OTHER CURRENT LIABILITIES	12,~~645~~529,~~836~~016	13,~~123~~358,~~201~~890
EMPLOYEE BENEFITS	~~337,338~~0	~~280~~200,~~710~~771
OTHER CURRENT LIABILITIES	12,~~308~~529,~~498~~016	~~842~~3,~~491~~158,119
NON CURRENT LIABILITIES	0100,283	738,~~937~~161,309
BANK CREDITS	02,428,733	738,~~937~~161,309
OTHER LIABILITIES	~~(217,946)~~	~~(405,692)~~
SHAREHOLDERS' EQUITY	~~798~~20,~~830~~384	4798,~~584,811~~830
CONTRIBUTED CAPITAL	2,593,872	2,593,~~972~~872
CAPITAL STOCK PAID (NOMINAL)	767,902	767,902
CAPITAL STOCK PAID UPDATE	956,093	956,093
CAPITAL STOCK UPDATE	956,093	956,093
PREMIUM ON STOCK SOLD	869,877	869,877
PREMIUM OM SOTCK SOLD)	859,877	869,877
CAPITAL INCREASE (DECREASE)	0(2,573,488)	(1,~~990~~795,~~939~~042)
ACCUMULATED PROFIT AND LEGAL RESERVE	(3,454,275)	(1,415,907)
ACCUMULATED PROFIT AND LEGAL RESERV	(4,000,503)	(3,454,275)
RESERVE FOR STOCK REPURCHASE	1,062,200	1,062,200
PROFIT	~~(597~~364,~~033)~~815	~~(487~~597,~~168)~~033

Filing Compare · GRUPO CASA SABA, S.A.B. DE C.V.